Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SH-BC-893, an orally active sphingolipid analog with anti-neoplastic properties, offers protection against ceramide-induced mitochondrial dysfunction and mitigates diet-induced obesity. This compound is utilized in the research of cancer and obesity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 8-10 weeks | $ 2,120.00 | |
50 mg | 8-10 weeks | $ 2,780.00 | |
100 mg | 8-10 weeks | $ 3,700.00 |
Description | SH-BC-893, an orally active sphingolipid analog with anti-neoplastic properties, offers protection against ceramide-induced mitochondrial dysfunction and mitigates diet-induced obesity. This compound is utilized in the research of cancer and obesity. |
Molecular Weight | 325.92 |
Formula | C19H32ClNO |
CAS No. | 1841409-92-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SH-BC-893 1841409-92-4 inhibitor inhibit